Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 123,634 $ 342,810
Cash held in escrow 17,101 4,079
Restricted cash 0 443
Real estate inventories 1,093,369 844,792
Due from affiliates 3,744 4,465
Investment in and advances to unconsolidated joint ventures 41 470
Goodwill 68,639 24,457
Other assets 133,968 43,998
Total assets 1,440,496 1,265,514
Liabilities    
Accounts payable 74,445 73,734
Accrued expenses and other liabilities 149,426 97,724
Due to affiliates 884 2,357
Warrant liability 0 9,185
Notes and other debts payable, net 505,422 461,117
Total liabilities 730,177 644,117
Commitments and contingencies (Note 11)
Stockholders’ equity:    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of December 31, 2022 and December 31, 2021, respectively 0 0
Common stock, $0.0001 par value, 500,000,000 shares authorized, 42,110,794 issued and 40,884,268 outstanding as of December 31, 2022, 46,281,091 issued and outstanding as of December 31, 2021 4 5
Additional paid-in capital 497,598 535,345
Retained earnings 158,348 84,797
Total stockholders’ equity 655,950 620,147
Noncontrolling interests 54,369 1,250
Total equity 710,319 621,397
Total liabilities and equity $ 1,440,496 $ 1,265,514